LENZ – lenz therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LENZ

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/19

07:02 pm

lenz

Form 4 LENZ Therapeutics, Inc. For: Nov 17 Filed by: Olsson Shawn

Medium Report

Form 4 LENZ Therapeutics, Inc. For: Nov 17 Filed by: Olsson Shawn

Report

11/17

04:38 pm

lenz

Form 144 LENZ Therapeutics, Inc. Filed by: Olsson Shawn

Medium Report

Form 144 LENZ Therapeutics, Inc. Filed by: Olsson Shawn

Report

11/14

04:39 pm

lenz

Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP

Low Report

Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP

Report

11/14

04:05 pm

lenz

Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

Low Report

Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

Report

11/10

04:49 pm

lenz

Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.

High Report

Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.

Report

11/10

04:14 pm

lenz

Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: MCCOLLUM JAMES W

High Report

Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: MCCOLLUM JAMES W

Report

11/7

07:42 pm

lenz

Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: Chevallard Daniel R.

Low Report

Form 4 LENZ Therapeutics, Inc. For: Nov 07 Filed by: Chevallard Daniel R.

Report

11/7

04:47 pm

lenz

Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Low Report

Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Report

11/7

11:14 am

lenz

Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: FMR LLC

Low Report

Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: FMR LLC

Report

11/5

04:11 pm

lenz

Form 10-Q LENZ Therapeutics, Inc. For: Sep 30

Medium Report

Form 10-Q LENZ Therapeutics, Inc. For: Sep 30

Report

11/5

08:23 am

lenz

Form 8-K LENZ Therapeutics, Inc. For: Nov 05

High Report

Form 8-K LENZ Therapeutics, Inc. For: Nov 05

Report

10/17

06:14 pm

lenz

Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: BlackRock, Inc.

Medium Report

Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: BlackRock, Inc.

Report

10/8

04:41 pm

lenz

Form 8-K LENZ Therapeutics, Inc. For: Oct 08

Medium Report

Form 8-K LENZ Therapeutics, Inc. For: Oct 08

Report

10/2

04:40 pm

lenz

Form 4 LENZ Therapeutics, Inc. For: Sep 30 Filed by: Versant Vantage II, L.P.

Low Report

Form 4 LENZ Therapeutics, Inc. For: Sep 30 Filed by: Versant Vantage II, L.P.

Report

9/30

08:07 am

lenz

Form 8-K LENZ Therapeutics, Inc. For: Sep 30

Low Report

Form 8-K LENZ Therapeutics, Inc. For: Sep 30

Report

9/22

04:24 pm

lenz

Form 4 LENZ Therapeutics, Inc. For: Sep 18 Filed by: Versant Vantage II, L.P.

Low Report

Form 4 LENZ Therapeutics, Inc. For: Sep 18 Filed by: Versant Vantage II, L.P.

Report

9/22

04:21 pm

lenz

Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.

Low Report

Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.